CCOC(=O)C1(C)NC(c2ccc(OC)cc2OC)C2C(=O)N(CC)C(=O)C21
The rule of three is typically followed by orally active drugs, which have a molecular weight of <300, a c LogP of ≤3, a hydrogen bond donor count of ≤3 and a hydrogen bond acceptor count of ≤3. Does the molecule comply with the rule of three?